Additional file 6: of Lamivudine plus tenofovir combination therapy versus lamivudine monotherapy for HBV/HIV coinfection: a meta-analysis

Abstract

Figure S6. Galbraith plots of HBV virological response rate(A), levels of HBV DNA(B), subgroups analysis of southern China(C), RCTs(D), 24 weeks(E), and 48 weeks(F). (TIF 6228 kb